Extended Data Fig. 9: Targeted metabolomics profiling in Slc7a11-null or inhibited DC.
From: Targeting SLC7A11 improves efferocytosis by dendritic cells and wound healing in diabetes
a, Peak intensity of several metabolites (absolute concentrations via targeted metabolomics) in the pellet of WT, Slc7a11 KO, and erastin-treated dendritic cells at steady state or upon efferocytosis (n = 4 biological replicates per condition; ****P < 0.0001 via One-way ANOVA with Tukey’s multiple comparisons test). Box and whiskers show minimum to maximum values with all independent replicates, center denotes median.
